| Title : Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson's disease - An_2025_Mol.Neurodegener_20_110 |
| Author(s) : An H , Kang S , Shin J , Kim P , Kim S , Im S , Kim JH , Lee KW , Kim DH , Park JH , Park MH , Lee J , Park SK , Kim KP , Lee HM , Lee JH , Choi LS , Jeon HJ , Kim SY , Hwang IY , Bhalla M , Won W , Park HS , Yoo SK , Lee BD , Lee CJ , Pak YK |
| Ref : Mol Neurodegener , 20 :110 , 2025 |
| Abstract : |
| PubMedSearch : An_2025_Mol.Neurodegener_20_110 |
| PubMedID: 41107874 |
| Title : Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson's disease - An_2025_Mol.Neurodegener_20_110 |
| Author(s) : An H , Kang S , Shin J , Kim P , Kim S , Im S , Kim JH , Lee KW , Kim DH , Park JH , Park MH , Lee J , Park SK , Kim KP , Lee HM , Lee JH , Choi LS , Jeon HJ , Kim SY , Hwang IY , Bhalla M , Won W , Park HS , Yoo SK , Lee BD , Lee CJ , Pak YK |
| Ref : Mol Neurodegener , 20 :110 , 2025 |
| Abstract : |
| PubMedSearch : An_2025_Mol.Neurodegener_20_110 |
| PubMedID: 41107874 |
| Title : Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson's disease - An_2025_Mol.Neurodegener_20_110 |
| Author(s) : An H , Kang S , Shin J , Kim P , Kim S , Im S , Kim JH , Lee KW , Kim DH , Park JH , Park MH , Lee J , Park SK , Kim KP , Lee HM , Lee JH , Choi LS , Jeon HJ , Kim SY , Hwang IY , Bhalla M , Won W , Park HS , Yoo SK , Lee BD , Lee CJ , Pak YK |
| Ref : Mol Neurodegener , 20 :110 , 2025 |
| Abstract : |
| PubMedSearch : An_2025_Mol.Neurodegener_20_110 |
| PubMedID: 41107874 |